ArticleFrontiers in artificial intelligence2026
Redefining lightweight vision models for healthcare AI.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vision models for medical imaging often require tens of millions of parameters, raising questions about whether architectural efficiency can be achieved without sacrificing classification performance. We introduce MedLiT-seed (2.1 Million parameters) and MedLiT-nano (0.75 Million parameters), two ultra-lightweight vision transformers designed for efficient and scalable medical image analysis. Methods: MedLiT employs a streamlined Mixture-of-Experts (MoE) architecture with SwiGLU feedforward networks, grouped query attention, and depth-wise scaling. Models were pre-trained using masked autoencoding on ImageNet and MedMNIST, followed by fine-tuning on 12 MedMNIST 2D subsets. We evaluated performance across multiple configurations and compared against benchmark models including ResNet, MedViT, and AutoML systems. Results: MedLiT-seed achieved the highest Area Under Curve (AUC) on 4 subsets and second-highest on 2 others, outperforming models with 10-20× more parameters. MedLiT-nano achieved results comparable to, and even exceeding, ResNet-18 and AutoML baselines in several subsets. Transfer learning from ImageNet significantly improved convergence and generalization. Increasing embedding size yielded greater performance gains than increasing expert count. Conclusion: MedLiT demonstrates that MoE-based token routing represents a viable architectural pathway for achieving competitive accuracy relative to its floating-point operations (FLOP) across diverse medical imaging modalities on the order of 2M parameters. These results suggest that selectively routing computation through specialised experts, rather than scaling model size, can serve as an effective design principle for more compact medical vision models. Such architecture can be utilised for low-resource clinical environments and scalable fine-tuning across diverse healthcare tasks, though limitations on multi-label tasks highlight clear directions for future architectural refinement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.